[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$regns Graphic](https://lunarcrush.com/gi/w:26/t:$regns.png) $regns

Crypto project sees increased community engagement amidst market volatility. Regulatory concerns continue to weigh on investor sentiment.

### About $regns
A cryptocurrency project.  

### Insights [#](/topic/$regns/insights)
- $regns creators is up XXXXX% from the previous week.
- $regns engagements is up XXXXXXXX% from the previous month.
- $regns mentions is up XXXXX% from the previous week.

### Engagements: XXX [#](/topic/$regns/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$regns/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$regns/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXXXX +54%  
**1 Month**: XXXXX +1,866%  
**1-Year High**: XXXXX on 2025-06-18  
**1-Year Low**: X on 2025-05-13  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$regns/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$regns/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$regns/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Week**: X +33%  
**1-Year High**: X on 2025-06-18  
**1-Year Low**: X on 2025-04-29  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$regns/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$regns/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$regns/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $regns in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1 Week**: X +33%  
**1-Year High**: X on 2025-06-18  
**1-Year Low**: X on 2025-04-29  

**Top assets mentioned**
In the posts about $regns in the last XX hours

[uniQure N.V. (QURE)](/topic/$qure)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/regeneron-pharmaceuticals-inc)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn)
[Novartis AG (NVS)](/topic/$nvs)

**Top topics mentioned**
In the posts about $regns in the last XX hours

[$qures](/topic/$qures), [$qure](/topic/$qure), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [stocks healthcare](/topic/stocks-healthcare), [$regn](/topic/$regn), [niche](/topic/niche), [$rhhbys](/topic/$rhhbys), [$ptcts](/topic/$ptcts), [$15b](/topic/$15b), [generator](/topic/generator), [$clpt](/topic/$clpt), [clippy](/topic/clippy), [$nvs](/topic/$nvs), [$rhhby](/topic/$rhhby)

### Top Social Posts [#](/topic/$regns/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$CLPT fanatics have been screaming about this for years now. The lowest risk gene cell therapy programs you can make are for the CNS"  
[X Link](https://x.com/AB1001_disciple/status/1977777641811014077) [@AB1001_disciple](/creator/x/AB1001_disciple) 2025-10-13T16:45Z XXX followers, 3559 engagements


"It looks like AAV gene therapy is finding its niche: local delivery of relatively low doses (E10-E12 total vg) in tissues as contained as possible. Recent clinical wins by $QURE's AMT-130 (intra-parenchymal Huntington's) and $REGN's DB-OTO (intracochlear inherited deafness) support this trend. These follow prior approved drugs like $RHHBY's Luxturna (subretinal LCA2) and $PTCT's Upstaza (intra-parenchymal AADC deficiency) also delivered locally. $NVS' Zolgensma is a special case -- although delivered systemically at relatively high doses the infant BBB remains permissive allowing efficient"  
[X Link](https://x.com/GerardCaelles/status/1977771288660791721) [@GerardCaelles](/creator/x/GerardCaelles) 2025-10-13T16:19Z 1099 followers, 13.8K engagements


"Regeneron in 1/6 Charts $REGN's Blockbuster Decade Rev skyrocketed after '12 fueled by product success like Eylea & Dupixent rev hit $15B Growth has since cooled from +200% to less than XX% The company has matured from an growth story to an established FCF generator"  
[X Link](https://x.com/QualityReturn/status/1973419549115687279) [@QualityReturn](/creator/x/QualityReturn) 2025-10-01T16:07Z XXX followers, 1719 engagements